Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS INC | $4.60M | $0.80 | $50.00 | 6,150.00% | Strong Buy | 4 | N/A | N/A | 76.09% | 24.16% | |||
| PSTV | PLUS THERAPEUTICS INC | $42.54M | $0.25 | $7.67 | 2,991.53% | Strong Buy | 3 | 108.90% | N/A | 832.00% | 203.65% | |||
| CODX | CO-DIAGNOSTICS INC | $5.26M | $2.59 | $67.50 | 2,506.18% | Strong Buy | 2 | 613.35% | N/A | 34.31% | 30.54% | |||
| FBLG | FIBROBIOLOGICS INC | $17.17M | $0.25 | $5.50 | 2,065.35% | Strong Buy | 2 | N/A | N/A | -470.40% | -301.05% | |||
| NRXP | NRX PHARMACEUTICALS INC | $51.98M | $1.85 | $38.00 | 1,954.05% | Strong Buy | 4 | 1,551.03% | N/A | -610.91% | 1,049.22% | |||
| HUMA | HUMACYTE INC | $146.63M | $0.78 | $13.67 | 1,645.47% | Strong Buy | 3 | 480.57% | N/A | -15,036.89% | 780.69% | |||
| SGMO | SANGAMO THERAPEUTICS INC | $111.72M | $0.33 | $5.50 | 1,556.63% | Buy | 2 | 89.70% | N/A | 3,811.77% | 268.46% | |||
| PDSB | PDS BIOTECHNOLOGY CORP | $27.97M | $0.57 | $9.00 | 1,476.18% | Strong Buy | 2 | N/A | N/A | 237.82% | 64.78% | |||
| IMMP | IMMUTEP LTD | $58.21M | $0.40 | $5.50 | 1,292.41% | Buy | 2 | N/A | N/A | N/A | N/A | |||
| GUTS | FRACTYL HEALTH INC | $60.44M | $0.44 | $6.00 | 1,260.54% | Buy | 3 | 3,170.16% | N/A | -205.26% | 5.71% | |||
| HELP | CYBIN INC | $230.51M | $4.62 | $62.67 | 1,256.43% | Strong Buy | 3 | N/A | N/A | N/A | N/A | |||
| SLE | SUPER LEAGUE ENTERPRISE INC | $3.95M | $4.70 | $60.00 | 1,176.60% | Strong Buy | 2 | N/A | N/A | N/A | -76.02% | |||
| ENLV | ENLIVEX LTD | $24.78M | $1.02 | $13.00 | 1,174.51% | Strong Buy | 2 | N/A | N/A | 66.62% | 55.62% | |||
| VNRX | VOLITIONRX LTD | $22.96M | $0.19 | $2.25 | 1,103.21% | Strong Buy | 2 | 342.92% | N/A | -224.22% | 1,204.23% | |||
| OSTX | OS THERAPIES INC | $54.23M | $1.54 | $18.50 | 1,101.30% | Strong Buy | 2 | N/A | N/A | -85.59% | -34.77% | |||
| NRSN | NEUROSENSE THERAPEUTICS LTD | $18.53M | $0.75 | $8.50 | 1,028.82% | Strong Buy | 2 | N/A | N/A | -14,747.22% | 4,545.02% | |||
| SNTI | SENTI BIOSCIENCES INC | $24.19M | $0.92 | $10.33 | 1,023.15% | Strong Buy | 3 | N/A | N/A | -549.81% | -84.75% | |||
| ACET | ADICET BIO INC | $66.41M | $6.92 | $75.00 | 983.82% | Strong Buy | 2 | N/A | N/A | 8.40% | 6.95% | |||
| TVRD | TVARDI THERAPEUTICS INC | $33.02M | $3.52 | $38.00 | 979.55% | Strong Buy | 2 | -100.00% | N/A | -69.71% | -49.78% | |||
| RANI | RANI THERAPEUTICS HOLDINGS INC | $137.31M | $1.13 | $10.50 | 829.20% | Strong Buy | 2 | 196.39% | N/A | N/A | -543.98% | |||
| SXTP | 60 DEGREES PHARMACEUTICALS INC | $2.06M | $1.95 | $17.60 | 802.56% | Buy | 2 | 55.22% | N/A | N/A | N/A | |||
| HOVR | NEW HORIZON AIRCRAFT LTD | $76.11M | $1.72 | $14.50 | 743.02% | Strong Buy | 2 | N/A | N/A | N/A | N/A | |||
| DEFT | DEFI TECHNOLOGIES INC | $198.34M | $0.52 | $4.25 | 723.64% | Strong Buy | 2 | N/A | N/A | N/A | N/A | |||
| CTSO | CYTOSORBENTS CORP | $41.45M | $0.66 | $5.38 | 714.39% | Buy | 2 | 33.24% | N/A | N/A | N/A | |||
| ACRV | ACRIVON THERAPEUTICS INC | $64.32M | $1.66 | $13.50 | 713.25% | Strong Buy | 2 | N/A | N/A | -54.09% | -46.92% | |||
| CAN | CANAAN INC | $291.68M | $0.44 | $3.55 | 710.50% | Strong Buy | 5 | -15.99% | N/A | -267.70% | -194.21% | |||
| BMEA | BIOMEA FUSION INC | $80.60M | $1.14 | $9.00 | 689.47% | Strong Buy | 2 | N/A | N/A | -443.26% | -125.45% | |||
| CABA | CABALETTA BIO INC | $283.02M | $2.94 | $23.00 | 682.31% | Strong Buy | 2 | N/A | N/A | -22.76% | -16.73% | |||
| IFRX | INFLARX NV | $67.96M | $0.94 | $7.33 | 680.11% | Buy | 3 | 162.31% | N/A | -35.40% | -26.64% | |||
| NSRX | NASUS PHARMA LTD | $24.06M | $2.67 | $20.50 | 667.79% | Strong Buy | 2 | N/A | N/A | N/A | -2,574.41% | |||
| BTAI | BIOXCEL THERAPEUTICS INC | $33.02M | $1.51 | $11.50 | 661.59% | Strong Buy | 2 | 472.90% | N/A | N/A | -36.35% | |||
| RCT | REDCLOUD HOLDINGS PLC | $30.96M | $0.70 | $5.25 | 650.00% | Strong Buy | 2 | N/A | N/A | N/A | -1.68% | |||
| GNLX | GENELUX CORP | $107.53M | $2.40 | $18.00 | 650.00% | Strong Buy | 2 | N/A | N/A | 328.59% | 199.36% | |||
| APRE | APREA THERAPEUTICS INC | $8.73M | $0.76 | $5.50 | 621.78% | Buy | 2 | 169.29% | N/A | 64.78% | 50.59% | |||
| FEMY | FEMASYS INC | $32.57M | $0.56 | $4.00 | 618.13% | Strong Buy | 2 | 175.14% | N/A | 39.28% | 10.99% | |||
| TNYA | TENAYA THERAPEUTICS INC | $162.97M | $0.75 | $5.33 | 610.12% | Strong Buy | 3 | N/A | N/A | 615.90% | 516.74% | |||
| HOWL | WEREWOLF THERAPEUTICS INC | $38.15M | $0.79 | $5.50 | 599.75% | Strong Buy | 2 | N/A | N/A | -167.19% | -62.18% | |||
| AUTL | AUTOLUS THERAPEUTICS PLC | $364.62M | $1.37 | $9.50 | 593.43% | Buy | 2 | 100.12% | N/A | 7.27% | 2.91% | |||
| CLNN | CLENE INC | $62.72M | $5.33 | $35.50 | 566.67% | Strong Buy | 2 | 821.00% | N/A | -398.14% | 386.30% | |||
| PALI | PALISADE BIO INC | $313.52M | $1.89 | $12.25 | 548.15% | Strong Buy | 4 | N/A | N/A | -39.89% | -38.41% | |||
| INTZ | INTRUSION INC | $23.52M | $1.17 | $7.25 | 519.66% | Buy | 2 | N/A | N/A | -65.85% | -47.24% | |||
| MNOV | MEDICINOVA INC | $76.79M | $1.56 | $9.50 | 508.97% | Strong Buy | 2 | -100.00% | N/A | -7.24% | -6.61% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.